Open access
Jul 2026
CpG-Adjuvanted Heplisav-B Induces Strong Th1-Biased Innate Responses Compared to Alum-Adjuvanted HBV Vaccines in PLWH 2308661
Heplisav-B induces stronger Th1-skewed innate responses and increased B cell frequency than Engerix-B in PLWH within the first 24 hours of vaccination, while overall cellular composition and activation remain largely preserved.
Jenny M. Lee, Prasanthy Balasubramanian, Yufeng Liu et al.
· Journal of Immunology · 0 citations